Ovarian CancerInfo Center
Catching cancer early can save lives, but screening too often — without good reason — may be costly and harmful.
Cancer patients are winning the battle against the disease like never before, but age and race may play a role in determining survival odds.
Hormone replacement therapy (HRT) is used by millions of women to treat menopause. HRT, however, has been shown to pose health risks, including increasing the chances of getting ovarian cancer.
Diabetes patients may need to take extra precautions to lower their risk for cancer or catch it early.
The US Food and Drug Administration (FDA) has approved a new use for the cancer medication Avastin (bevacizumab), according to biotechnology company Genentech.
Gene mutations associated with higher rates of breast and ovarian cancer may pose a serious risk to Ashkenazi Jewish (AJ) women, even those without a family history of cancer. This prompted a call for more genetic cancer screening.
Customizing treatments based on a patient’s genetics has led to more effective cancer treatments. Now, researchers have reported using ovarian cancer tumor types to predict how much one medication might benefit patients.
Ovarian cancer is the second most common cancer of the female reproductive organs. It's common for this cancer to return after initial treatment, but two therapies used together may help fight this cancer.
Women who know they have certain BRCA gene mutations may consider surgery to remove their breasts or ovaries to lower their risk of developing deadly cancers. But there may be other less aggressive options that can reduce their risk.
Bisphosphonates are a class of medications commonly used to prevent bone loss and osteoporosis. Now, it seems these medications might have an additional benefit: protection against certain cancers.